Le Lézard
Classified in: Health
Subjects: TDS, TRI

skinbetter science® Presents Data at the 2018 American Academy of Dermatology Meeting in San Diego, CA


PHOENIX, Feb. 16, 2018 /PRNewswire/ -- skinbetter science announced today that data supporting the benefits of their innovative, potent antioxidant, Alto Defense Serumtm, will be presented at the 2018 American Academy of Dermatology Meeting in San Diego, February 16-19, 2018.

Alto Defense Serumtm was scientifically evaluated in three separate studies to:

The Protective Effects of a Topical Antioxidant System from Ultraviolet-induced Erythema in Human Skin (poster #6263) will be presented during the 'Pearls from the Posters Symposium' session (S045), and is scheduled as follows:

The Antioxidant Capacity of a Comprehensive Topical Antioxidant in Comparison to a Leading Antioxidant Serum in a Human Skin Model (poster #6642) and Clinical Evaluation of a Comprehensive Topical Antioxidant in Subjects with Mild to Moderate Photodamaged Skin (poster #6265) posters will be available for viewing in e-Poster format in the Poster Viewing/Presentation Area throughout the meeting.

About skinbetter science

The skinbetter science team of aesthetic experts has a profound understanding of skin aging and what it takes to help defy the effects of time. Tapping into a rich dermatological heritage, the team at skinbetter science set out to create a new paradigm in clinical skincare. Cutting-edge, data-driven science is the principal driving force behind all our unique formulations. skinbetter science's research and development group engineers breakthrough technology innovation to deliver the clinical efficacy essential to visible skin rejuvenation that inspires the trust of physicians and patients alike. skinbetter science is available exclusively through the leading dermatology, plastic surgery and medical aesthetics practices nationwide. To find an authorized skinbetter science physician near you, please visit www.skinbetter.com.

For more information on skinbetter science, please contact Melissa Palmieri at [email protected]

SOURCE skinbetter science


These press releases may also interest you

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...



News published on and distributed by: